Islay Capital Management’s Editas Medicine EDIT Stock Holding History

Islay Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$486	Hold	150	–	–	﹤0.01%	207
2026 Q1	$371	Hold	150	–	–	﹤0.01%	193
2025 Q4	$308	Sell	150 -150	-50%	-$433	﹤0.01%	208
2025 Q3	$1.04K	Hold	300	–	–	﹤0.01%	195
2025 Q2	$660	Hold	300	–	–	﹤0.01%	185
2025 Q1	$348	Hold	300	–	–	﹤0.01%	179
2024 Q4	$381	Hold	300	–	–	﹤0.01%	192
2024 Q3	$1.02K	Hold	300	–	–	﹤0.01%	189
2024 Q2	$1.4K	Hold	300	–	–	﹤0.01%	185
2024 Q1	$2.23K	Hold	300	–	–	﹤0.01%	182
2023 Q4	$3.04K	Hold	300	–	–	﹤0.01%	202
2023 Q3	$2.34K	Hold	300	–	–	﹤0.01%	198
2023 Q2	$2.47K	Hold	300	–	–	﹤0.01%	201
2023 Q1	$2.17K	Hold	300	–	–	﹤0.01%	208
2022 Q4	$2.66K	Hold	300	–	–	﹤0.01%	224
2022 Q3	$4K	Hold	300	–	–	﹤0.01%	226
2022 Q2	$4K	Hold	300	–	–	﹤0.01%	254
2022 Q1	$6K	Hold	300	–	–	0.01%	260
2021 Q4	$8K	Hold	300	–	–	0.01%	251
2021 Q3	$12K	Hold	300	–	–	0.01%	245
2021 Q2	$17K	Buy	+300	New	+$11.1K	0.01%	238
2021 Q1	–	Sell	-350	Closed	-$25K	–	288
2020 Q4	$25K	Sell	350 -150	-30%	-$6.16K	0.02%	205
2020 Q3	$14K	Buy	+500	New	+$16.3K	0.01%	225

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Islay Capital Management's EDIT Position: Q2 2026 in Review

Islay Capital Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 150 shares worth $486. The position accounts for ﹤0.01% of the portfolio, ranked #207.

Islay Capital Management first reported a position in EDIT in Q3 2020 and has held it in 23 quarters since. The position peaked at $25K in Q4 2020. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Islay Capital Management held 150 shares of Editas Medicine worth $486 as of Q2 2026.
Islay Capital Management left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Islay Capital Management's portfolio in Q2 2026, its #207 holding.
Islay Capital Management first reported a position in Editas Medicine in Q3 2020 and has held it in 23 quarters since.
Islay Capital Management's Editas Medicine position peaked at $25K in Q4 2020.
216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Islay Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.